Theresa Schulze
Nurse Practitioner · River Edge, NJNPI 1508450446
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 504 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,498, 2.0 times the $1,248 reported in 2021. Among nurse practitioner clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 504 payments — averaging $19.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$2K
- CSL Behring$1K
- Sanofi$1K
- Takeda Pharmaceuticals U.S.A., Inc.$907
- Grifols USA, LLC$425
- plus $2K from 31 others
What the payments were for
- Consulting fees$651%
- Food & beverage$9,43598%
- Education$971%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 50 | $1,809 |
| GSK | 91 | $1,752 |
| CSL Behring | 69 | $1,243 |
| Sanofi | 74 | $1,143 |
| Takeda Pharmaceuticals U.S.A., Inc. | 72 | $907 |
| Grifols USA, LLC | 23 | $425 |
| Amgen | 10 | $285 |
| Optinose US, Inc. | 13 | $216 |
| Novartis | 10 | $205 |
| Regeneron Healthcare Solutions, Inc. | 12 | $202 |
| Covis Pharma GmbH | 12 | $168 |
| Kaleo, Inc. | 11 | $158 |
| Pfizer | 7 | $108 |
| LEO Pharma Inc. | 6 | $99 |
| Galderma Laboratories, L.p. | 1 | $95 |
| ADMA Biomanufacturing LLC | 5 | $79 |
| Teva Pharmaceuticals USA, Inc. | 5 | $71 |
| X4 Pharmaceuticals, Inc. | 1 | $64 |
| Sanofi-aventis U.S. LLC | 1 | $62 |
| Ionis Pharmaceuticals, Inc. | 3 | $59 |
| Blueprint Medicines Corporation | 3 | $49 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $43 |
| AbbVie | 3 | $42 |
| Lilly USA, LLC | 2 | $36 |
| Invivyd Inc | 2 | $35 |
| Cycle Pharmaceuticals Inc | 2 | $33 |
| Biocryst US Sales Co., LLC | 2 | $33 |
| Hikma Pharmaceuticals USA | 2 | $28 |
| Bio Products Laboratory USA, Inc. | 2 | $27 |
| Kedrion Biopharma, Inc. | 1 | $21 |
| Organon | 1 | $17 |
| Merck | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| Phadia US Inc. | 1 | $13 |
| Boehringer Ingelheim | 1 | $13 |
| Octapharma USA, Inc. | 1 | $13 |
| Aimmune Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,596 in reported general payments places this provider in the 95th percentile of 2,138 nurse practitioner providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 18 | $250 |
| Azithromycin | 27 | $98 |
| Prednisone | 44 | $95 |
| Doxycycline Hyclate | 12 | $76 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in River Edge
- Nancy BonnetMorristown$407K
- Vanessa CoppolaCloster$205K
- Olufunmilayo IloriUnion$133K
- Janice BeitzHaddon Heights$75K
- Adewale AdefowojuUnion$70K
- Sophia KimEnglewood$70K
- Elizabeth FletcherCamden$62K
- Lannae EwingLinwood$39K
- Beth SavageNew Brunswick$34K
- Tina OcchiutoMorristown$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.